Zhejiang Jolly Pharmaceutical Co Ltd Net Asset Momentum
Zhejiang Jolly Pharmaceutical Co Ltd net asset momentum. Zhejiang Jolly Pharmaceutical Co Ltd (300181) recorded a net asset momentum of 15.0% as of December 2025, with net assets of CN¥3.24 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore capital reinvestment ratio of Zhejiang Jolly Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Net asset momentum of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. This chart tracks Zhejiang Jolly Pharmaceutical Co Ltd's year-over-year net asset growth across 19 annual reporting periods from 2007 to 2025. The most recent momentum reading is +15.0%, with net assets of CN¥3.24 Billion CNY as of December 2025. See 300181 book value for net asset value and shareholders' equity analysis.
Zhejiang Jolly Pharmaceutical Co Ltd Net Asset Momentum by Year (2007–2025)
Zhejiang Jolly Pharmaceutical Co Ltd net asset momentum by year from 2007 to 2025. The table below shows the complete annual net asset history for Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Zhejiang Jolly Pharmaceutical Co Ltd (300181) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥3.24 Billion | CN¥4.71 Billion | CN¥1.47 Billion | ▲ +15.0% |
| 2024 | CN¥2.82 Billion | CN¥3.99 Billion | CN¥1.17 Billion | ▲ +1.6% |
| 2023 | CN¥2.77 Billion | CN¥3.63 Billion | CN¥853.09 Million | ▲ +0.5% |
| 2022 | CN¥2.76 Billion | CN¥3.64 Billion | CN¥879.19 Million | ▲ +39.2% |
| 2021 | CN¥1.98 Billion | CN¥2.75 Billion | CN¥765.31 Million | ▲ +15.3% |
| 2020 | CN¥1.72 Billion | CN¥2.47 Billion | CN¥750.43 Million | ▲ +22.1% |
| 2019 | CN¥1.41 Billion | CN¥2.05 Billion | CN¥642.86 Million | ▲ +1.5% |
| 2018 | CN¥1.39 Billion | CN¥2.11 Billion | CN¥726.50 Million | ▼ -6.9% |
| 2017 | CN¥1.49 Billion | CN¥2.15 Billion | CN¥662.06 Million | ▲ +1.3% |
| 2016 | CN¥1.47 Billion | CN¥2.04 Billion | CN¥566.00 Million | ▲ +2.5% |
| 2015 | CN¥1.44 Billion | CN¥1.85 Billion | CN¥414.94 Million | ▲ +64.7% |
| 2014 | CN¥871.76 Million | CN¥1.18 Billion | CN¥309.75 Million | ▲ +12.8% |
| 2013 | CN¥772.52 Million | CN¥941.90 Million | CN¥169.38 Million | ▲ +9.4% |
| 2012 | CN¥705.92 Million | CN¥864.19 Million | CN¥158.27 Million | ▲ +3.2% |
| 2011 | CN¥683.92 Million | CN¥843.91 Million | CN¥159.99 Million | ▲ +230.1% |
| 2010 | CN¥207.17 Million | CN¥348.64 Million | CN¥141.47 Million | ▲ +25.0% |
| 2009 | CN¥165.70 Million | CN¥297.77 Million | CN¥132.07 Million | ▲ +11.1% |
| 2008 | CN¥149.11 Million | CN¥279.87 Million | CN¥130.76 Million | ▲ +3.2% |
| 2007 | CN¥144.47 Million | CN¥251.25 Million | CN¥106.79 Million | — |